Common Stock
There's nothing like an upside earnings surprise to juice the price of a company's shares.
/PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it was renaming and...
CRY earnings call for the period ending September 30, 2021.
CryoLife (CRY) delivered earnings and revenue surprises of 420.00% and -0.95%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
/PRNewswire/ -- Third Quarter and Recent Business Highlights: Achieved total revenues of $72.2 million in the third quarter 2021 versus $65.1 million in the...
CryoLife (CRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CRY earnings call for the period ending June 30, 2021.
CryoLife (CRY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, annou...
The Techncial Trigger Driven Option Trade Right Before Cryolife Inc (NYSE:CRY) Earnings.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in CryoLife, Inc. (CRY), where a total of 2,449 contracts have traded so far, representing approximately 244,900 underlying shares..
CRY earnings call for the period ending March 31, 2021.
CryoLife (CRY) delivered earnings and revenue surprises of 27.27% and 15.21%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?